Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its upcoming participation in the 7th Annual Evercore ISI HealthCONx Conference. The company's management will engage in a fireside chat on Tuesday, December 3, 2024, at 9:35 a.m. Eastern Time.
The presentation will be accessible via live webcast through the Investors section of Kiniksa's website at www.kiniksa.com. A replay of the presentation will be made available on the company's website within approximately 48 hours following the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha annunciato la sua prossima partecipazione alla 7ª Conferenza Annuale Evercore ISI HealthCONx. Il management dell'azienda parteciperà a una chiacchierata informale martedì 3 dicembre 2024, alle 9:35 ora orientale.
La presentazione sarà accessibile tramite webcast in diretta nella sezione Investitori del sito web di Kiniksa all'indirizzo www.kiniksa.com. Una registrazione della presentazione sarà resa disponibile sul sito dell'azienda entro circa 48 ore dopo l'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha anunciado su próxima participación en la 7ª Conferencia Anual Evercore ISI HealthCONx. La gerencia de la compañía participará en una charla informal el martes 3 de diciembre de 2024, a las 9:35 a.m. hora del este.
La presentación será accesible a través de una transmisión en vivo por medio de la sección de Inversores en el sito web de Kiniksa en www.kiniksa.com. Una repetición de la presentación estará disponible en el sitio de la compañía aproximadamente 48 horas después del evento.
키니사 제약 (Nasdaq: KNSA)는 제7회 에버코어 ISI 헬스CONx 컨퍼런스에 참여할 예정임을 발표했습니다. 회사 경영진은 2024년 12월 3일 화요일 오전 9시 35분(동부 표준시)에 파이어사이드 채팅에 참여할 것입니다.
프레젠테이션은 키니사의 웹사이트 투자자 섹션을 통해 실시간 웹캐스트로 접속할 수 있습니다. 이벤트 이후 약 48시간 이내에 회사 웹사이트에서 프레젠테이션의 재생을 제공할 예정입니다.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) a annoncé sa prochaine participation à la 7ème Conférence Annuelle Evercore ISI HealthCONx. La direction de l'entreprise participera à une discussion informelle le mardi 3 décembre 2024, à 9h35 heure de l'Est.
La présentation sera accessible en direct par webdiffusion sur la section Investisseurs du site web de Kiniksa à l'adresse www.kiniksa.com. Un enregistrement de la présentation sera disponible sur le site de l'entreprise dans un délai d'environ 48 heures après l'événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine bevorstehende Teilnahme an der 7. jährlichen Evercore ISI HealthCONx-Konferenz bekannt gegeben. Das Management des Unternehmens wird am Dienstag, den 3. Dezember 2024, um 9:35 Uhr Eastern Time an einem informellen Gespräch teilnehmen.
Die Präsentation wird über einen Live-Webcast im Investorenbereich der Kiniksa-Website unter www.kiniksa.com zugänglich sein. Eine Aufzeichnung der Präsentation wird innerhalb von etwa 48 Stunden nach der Veranstaltung auf der Website des Unternehmens verfügbar sein.
- None.
- None.
LONDON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024 at 9:35 a.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
FAQ
When is Kiniksa Pharmaceuticals (KNSA) presenting at the Evercore ISI HealthCONx Conference 2024?
How can I watch Kiniksa Pharmaceuticals' (KNSA) presentation at the 2024 HealthCONx Conference?
When will the replay of Kiniksa's (KNSA) 2024 HealthCONx Conference presentation be available?
